Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

TIDES USA: Oligonucleotide & Peptide Therapeutics
April 26-29, 2027
Hynes Convention CenterBoston, MA

Ben Kleinstiver, PhD
Associate Professor at Massachusetts General Hospital & Harvard Medical School
Speaker

Profile

Dr. Kleinstiver is an Associate Professor in the Center for Genomic Medicine and Department of Pathology at Massachusetts General Hospital and Harvard Medical School and is the Kayden-Lambert MGH Research Scholar. He is a biochemist by training and now runs a research lab focused on genome editing technology development seeking to optimize new methods to modify genetic sequences. Some of the major goals in the Kleinstiver lab are to develop safe effective and versatile tools that can correct genetic mutations that underlie human disease while solving challenges that can expand access of gene editing treatments to a wider base of patients.

Agenda Sessions

  • Development of Bespoke Genome Editing Technologies to Treat Disease

    9:20am